A ciliary neuronotrophic factor from peripheral nerve and smooth muscle which is not retrogradely transported

Developmental expression of messenger RNA levels of the alpha subunit of the GTP-binding protein, Gz, in the mouse nervous system

There has been recent evidence that Gz may play a role in the transmission of the neurotrophic signal from nerve terminals to the cell bodies [Johanson, S.O., Crouch, M.F., Hendry, I.A., Signal transduction from membrane to nucleus: the special case for neurons, Neurochem. Res. 21 (1996) 779-785]. We examined the developmental expression of the alpha subunit of Gz (Gzalpha) in the peripheral and central nervous systems of the mouse. Our laboratory has developed a quantitative reverse transcription-polymerase chain reaction (RT-PCR) for Gzalpha which makes use of a fragment of the PCR product shortened by 107 base pairs creating a standard which mimics the original RNA. Serial dilutions of the mouse RNA with a constant concentration of mimic RNA were made and the point where equal amounts of product are formed allows accurate measurement of Gzalpha mRNA in the tissue. We have demonstrated that in the developing mouse superior cervical ganglion (SCG), dorsal root ganglion (DRG) and trigeminal ganglion the expression of Gzalpha mRNA is highest perinatally. From 3 weeks of age, in all tissues with the exception of the SCG, Gzalpha mRNA levels fall to lower levels in the adult animal. The developmental pattern of expression of Gzalpha in both the cerebellum and the brain differs from the peripheral nervous system. In the cerebellum, Gzalpha mRNA expression is highest around birth and in the brain it is highest around third postnatal week and then the levels decline as adulthood is approached. These results suggest that the highest level of Gzalpha mRNA is expressed at the time when target tissue innervation is occurring. This further strengthens the hypothesis that Gzalpha is important in the transfer of information from target tissues to the innervating nerve cells.

Retrograde axonal transport of the alpha subunit of the GTP-binding protein Gz to the nucleus of sensory neurons

Nerve cells are exquisitely sensitive to target tissue derived factors and the discovery that nerve growth factor could be retrogradely transported in axons suggested that the physical translocation of proteins along the axon could be a mechanism to convey this signal. This message is not due to the neurotrophic factor itself but rather due to second messengers generated by interaction with receptors. We have previously demonstrated the retrograde axonal transport of the alpha subunits of two putative second messenger molecules Gi and Gz. We have investigated more thoroughly the transport of the alpha subunit of Gz (Gz alpha) and in order to be more certain that the immunoreactivity seen is due to Gz alpha, we have made antibodies to peptides from both the N- and C-terminal regions of Gz alpha, which recognise the same 41 kDa band on Western blots of brain and sciatic nerve extracts. This band is eliminated when the antibodies are previously incubated with the specific peptide to which they were made. Using these antibodies for immunohistochemical localisation for Gz alpha, we now report that the GTP-binding protein Gz, is not only retrogradely transported in axons but that it translocates to the neuronal nucleus. Furthermore, the levels seen in the nuclear compartment decline after axotomy or ligation of the mice under ether anaesthetic, suggesting it is the retrogradely transported Gz alpha that is accumulating in the nucleus after activation at the nerve terminal.

Further characterization of the effects of brain-derived neurotrophic factor and ciliary neurotrophic factor on axotomized neonatal and adult mammalian motor neurons

Neurotrophins and neural cytokines are two broad classes of neurotrophic factors. It has been reported that ciliary neurotrophic factor (CNTF) and brain-derived neurotrophic factor (BDNF) prevent the degeneration of axotomized neonatal motor neurons. In addition, BDNF is transported retrogradely to alpha-motor neurons following injection into the muscle, and patterns of BDNF expressed in spinal cord and muscle suggest a physiological role for this factor in motor neurons. In the present study, we characterize the effects of BDNF on axotomized neonatal facial motor neurons and extend these observations to adult models of motor neuron injury (axotomy-induced phenotypic injury of lumbar motor neurons). BDNF reduces axotomy-induced degeneration of neonatal neurons by 55% as determined by Nissl staining (percentage of surviving neurons in vehicle-treated cases, 25%; in BDNF-treated cases, 80%). Rescued neurons have an intact organelle structure but appear smaller and slightly chromatolytic on electron microscopic analysis. As demonstrated by intense retrograde labeling with horseradish peroxidase (HRP) applied to the proximal stump of the facial nerve, neurons rescued by BDNF have intact mechanisms of fast axonal transport. CNTF did not appear to have significant effects on neonatal motor neurons, but the lack of efficacy of this factor may be caused by its rapid degradation at the application site. BDNF is not capable of reversing the axotomy-induced reduction in transmitter markers [i.e., the acetylcholine-synthesizing enzyme choline acetyltransferase (ChAT) or the degrading enzyme acetylcholinesterase (AChE) in neonatal or adult animals or the axotomy-induced up-regulation of the low-affinity neurotrophin receptor p75NGFR (nerve growth factor receptor) in adult motor neurons. However, BDNF appears to promote the expression of p75NGFR in injured neonatal motor neurons. In concert, the findings of the present study suggest that BDNF can significantly prevent cell death in injured motor neurons. However, this neurotrophin may not be a retrograde signal associated with the induction and/or maintenance of some mature features of motor neurons, particularly their transmitter phenotype.

Ciliary neurotrophic factor as an injury factor

This article reviews recent evidence suggesting that endogenous ciliary neurotrophic factor may be involved in neural responses to injury, and discusses the possibility that ciliary neurotrophic factor could have therapeutic applications in a clinical setting. The functional relevance of ciliary neurotrophic factor in non-injury situations is also evaluated, with emphasis on its possible roles in embryonic development.

Peripheral nerve regeneration: role of growth factors and their receptors

Growth factors play a central role in the regulation of normal and injury-induced regenerative cell growth. The purpose of this article is to summarize the available data on the expression of different growth factors and their receptors in the injured peripheral nervous system and to discuss their possible role in promoting peripheral nerve regeneration.

Effect of ciliary neuronotrophic factor on somatostatin expression in chick ciliary ganglion neurons

The normal development of somatostatin (SOM) expression in neurons of the chick ciliary ganglion and the effects of ciliary neuronotrophic factor (CNTF) on SOM induction in cultured ciliary ganglion neurons, were studied by immunocytochemical techniques. SOM immunoreactivity was first detectable in some neurons of the ganglion at embryonic day (E)8 and between E14 to hatch. 44-46% of the neuronal population contained the peptide. It was inferred that essentially all choroid neurons, which constitute 50% of the neuronal population, contain SOM. Culture studies indicated that CNTF supported both the SOM positive choroid neurons and the SOM negative ciliary neurons. Although CNTF was necessary for the survival and maturation of cultured ciliary ganglion neurons, it did not influence either the induction or maintenance of SOM expression in these neurons. CNTF may instead act as a permissive factor, allowing the induction of SOM in neurons of the ciliary ganglion by other, more specific, factors.

Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system

The neurocytokine ciliary neurotrophic factor (CNTF) was described originally as an activity that supports the survival of neurons of the chicken ciliary ganglia in vitro. The widespread expression of CNTF and its principal binding protein, CNTF receptor alpha, in the central and peripheral nervous systems suggests a broader trophic role for this peptide. In the present study, we report that CNTF prevents axotomy-induced cell death of neurons in the anteroventral and anterodorsal thalamic nuclei of the adult rat. Using the polymerase chain reaction, we also demonstrate the presence of CNTF and CNTF receptor alpha mRNA in these same thalamic nuclei. The coincidence of CNTF and its receptor in a population of neurons responding to the factor suggests a paracrine function for CNTF. The present findings establish that CNTF has significant effects on neurons of the central nervous system in vivo and demonstrate that neurocytokines can prevent cell death in the adult central nervous system.

Retrograde factors in peripheral nerves

The relationship between the neuron and its target is explored and the possible mechanisms for achieving correct connections are analysed. The most plausible mechanism is the presence of a retrograde intra-axonal message from the target to the neuronal cell body. The molecular form of the message and the mechanisms to achieve this signal transduction are discussed and it is proposed that there are two types of neurotrophic factors. One has a short-acting second messenger, itself incapable of surviving for the time required for transport to the cell body and thus requiring the transport of the message-generating complex to the cell body. The other has a long-lasting second messenger complex which is well able to survive the transport to the cell body so that there is no need for the transport of the neurotrophic factor itself. Thus all neurotrophic factors do not themselves require retrograde axonal transport and such non-transportable factors may generate intricate messages due to associations of signal transduction molecules via binding sites such as phosphorylated tyrosines and the src homology domain 2.

Cytokines in neural regeneration

Growth factors with already established multiple effects on non-neural cells continue to be of considerable interest to researchers with regard to the nervous system, where regulation of cell maintenance and plasticity in relation to lesion and regeneration is part of their functional repertoire. Fibroblast growth factors, interleukins, and type beta transforming growth factors are prominent representatives of such proteins. Ciliary neurotrophic factor is another multifunctional neurokine. The proposed role of this molecule as a 'lesion factor', however, is still not firmly settled.

Changes in cytoskeletal protein synthesis following axon injury and during axon regeneration

Injury to the axons of facial motoneurons stimulates increases in the synthesis of actin, tubulins, and GAP-43, and decreases in the synthesis of neurofilament proteins: mRNA levels change correspondingly. In contrast to this robust response of peripheral neurons to axotomy, injured central nervous system neurons show either an attenuated response that is subsequently aborted (rubrospinal neurons) or overall decreases in cytoskeletal protein mRNA expression (corticospinal and retinal ganglion neurons). There is evidence that these changes in synthesis are regulated by a variety of factors, including loss of endoneurially or target-derived trophic factors, positive signals arising from the site of injury, changes in the intraaxonal turnover of proteins, and substitution of target-derived trophic support by factors produced by glial cells. It is concluded that there is, as yet, no coherent explanation for the upregulation or downregulation of any of the cytoskeletal proteins following axotomy or during regeneration. In considering the relevance of these changes in cytoskeletal protein synthesis to regeneration, it is emphasized that they are unlikely to be involved in the initial outgrowth of the injured axons, both because transit times between cell body and injury site are too long, and because sprouting can occur in isolated axons. Injury-induced acceleration of the axonal transport of tubulin and actin in the proximal axon is likely to be more important in providing the cytoskeletal protein required for initial axonal outgrowth. Subsequently, the increased synthesis and transport velocity for actin and tubulin increase the delivery of these proteins to support the increased volume of the maturing regenerating axons. Reduction in neurofilament synthesis and changes in neurofilament phosphorylation may permit the increased transport velocity of the other cytoskeletal proteins. There is little direct evidence that alterations in cytoskeletal protein synthesis are necessary for successful regeneration, nor are they sufficient in the absence of a supportive environment. Nevertheless, the correlation that exists between a robust cell body response and successful regeneration suggests that an understanding of the regulation of cytoskeletal protein synthesis following axon injury must be a part of any successful strategy to improve the regenerative capacity of the central nervous system.